“…Together, these findings support the working model that innate immune activation, a hypothesized prerequisite to IDR progression, is unique to clozapine, while lymphopenia occurs via an independent mechanism that is conserved among analogues. Clozapine-altered chemistry parameters (e.g., ALT, BUN) may be relevant for other adverse effects including liver injury (Wu Chou et al, 2014;Oates et al, 2018;Gunther and Dopheide, 2023) and acute interstitial nephritis (Davis and Kelly, 2019;McLoughlin et al, 2022;Vantipalli et al, 2022), and these IDRs may share early mechanisms. Indeed, with repeat clozapine dosing, increased hepatic covalent binding (Gardner et al, 2005;Ip and Uetrecht, 2008) and inflammatory changes in the liver (Jia et al, 2014;Zlatkovic et al, 2014;Sernoskie et al, 2023) and the kidney (Mohammed et al, 2020) have been observed.…”